Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.000

+0.040 (2.04%)

At close: May 22, 2026, 4:00 PM EDT

1.990

-0.010 (-0.50%)

After-hours: May 22, 2026, 7:49 PM EDT

Allogene Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	30.31	51.69	75.22	83.16	61.9	173.31
Short-Term Investments	236.58	198.52	217.26	365.54	455.42	283.99
Cash & Short-Term Investments	266.89	250.21	292.48	448.7	517.32	457.3
Cash Growth	-4.70%	-14.45%	-34.82%	-13.26%	13.12%	-44.76%
Other Current Assets	6.41	7.54	10.91	10.42	11.5	14.02
Total Current Assets	273.29	257.75	303.39	459.12	528.82	471.32
Net Property, Plant & Equipment	108.84	112.73	131.26	163.18	196.43	181.02
Long-Term Investments	-	8.04	80.67	3.65	76.47	382.38
Other Long-Term Assets	13.82	37.39	33.39	16.9	19.86	16.11
Total Assets	395.96	415.91	548.71	642.84	821.58	1,051
Accounts Payable	4.93	4.27	5.39	5.9	13.89	10.26
Accrued Expenses	23.4	28.24	30.13	31.18	39.74	37.5
Unearned Revenue	-	-	-	-	0.1	0.16
Total Current Liabilities	28.33	32.51	35.52	37.08	53.73	47.91
Long-Term Leases	72.63	75.05	83.25	88.35	95.12	69.93
Other Long-Term Liabilities	16.12	15.8	7.76	5.18	5.85	7.79
Total Long-Term Liabilities	88.75	90.85	91.01	93.53	100.97	77.72
Total Liabilities	117.08	123.36	126.53	130.6	154.7	125.63
Common Stock	0.25	0.23	0.21	0.17	0	0.14
Additional Paid-in Capital	2,332	2,303	2,242	2,075	1,912	1,822
Accumulated Other Comprehensive Income	-0.18	0.27	-0.09	-0.96	-9.93	-2.57
Retained Earnings	-2,053	-2,011	-1,820	-1,562	-1,235	-894.55
Shareholders' Equity	278.88	292.54	422.18	512.23	666.88	925.2
Total Liabilities & Equity	395.96	415.91	548.71	642.84	821.58	1,051
Total Debt	72.63	75.05	83.25	88.35	95.12	69.93
Net Cash (Debt)	194.25	175.17	209.23	360.35	422.2	387.37
Net Cash Growth	10.90%	-16.28%	-41.94%	-14.65%	8.99%	-50.15%
Net Cash Per Share	0.86	0.79	1.07	2.30	2.95	2.85
Book Value	278.88	292.54	422.18	512.23	666.88	925.2
Book Value Per Share	1.23	1.33	2.17	3.26	4.66	6.81
Tangible Book Value	278.88	292.54	422.18	512.23	666.88	925.2
Tangible Book Value Per Share	1.23	1.33	2.17	3.26	4.66	6.81

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q